SlideShare une entreprise Scribd logo
1  sur  31
ANTIMICROBIAL DRUGS
MECHANISMS OF ACTION OF
    ANTIBACTERIAL DRUGS
   Mechanism of action
    include:
       Inhibition of cell wall
        synthesis
       Inhibition of protein
        synthesis
       Inhibition of nucleic acid
        synthesis
       Inhibition of metabolic
        pathways
       Interference with cell
        membrane integrity
MECHANISMS OF ACTION OF
ANTIBACTERIAL DRUGS
   Inhibition of Cell wall synthesis
        Bacteria cell wall unique in
         construction
             Contains peptidoglycan
        Antimicrobials that interfere with
         the synthesis of cell wall do not
         interfere with eukaryotic cell
             Due to the lack of cell wall in animal
              cells and differences in cell wall in
              plant cells
        These drugs have very high
         therapeutic index
             Low toxicity with high effectiveness
        Antimicrobials of this class include
             β lactam drugs
             Vancomycin
             Bacitracin
MECHANISMS OF ACTION OF
ANTIBACTERIAL DRUGS
                Penicillins and cephalosporins
                    Part of group of drugs
                     called β –lactams
                         Have shared chemical
                          structure called β-lactam
                          ring
                    Competitively inhibits
                     function of penicillin-
                     binding proteins
                         Inhibits peptide bridge
                          formation between glycan
                          molecules
                         This causes the cell wall
                          to develop weak points at
                          the growth sites and
                          become fragile.
MECHANISMS OF ACTION OF
ANTIBACTERIAL DRUGS

   The weakness in the cell
    wall causes the cell to
    lyze.
MECHANISMS OF ACTION
OF ANTIBACTERIAL DRUGS

   The weakness in the cell wall
    causes the cell to lyze.
   Penicillins and cephalosporins are
    considered bactericidal.
   Penicillins are more effective
    against Gram+ bacteria. This is
    because Gram + bacteria have
    penicillin binding proteins on
    their walls.
MECHANISMS OF ACTION
OF ANTIBACTERIAL DRUGS
   The cephalosporins
       Chemical structures make them resistant to
        inactivation by certain β-lactamases
       Tend to have low affinity to penicillin-binding
        proteins of Gram + bacteria, therefore, are most
        effective against Gram – bacteria.
       Chemically modified to produce family of related
        compounds
            First, second, third and fourth generation
             cephalosporins
MECHANISMS OF ACTION
OF ANTIBACTERIAL DRUGS
   Vancomycin
       Inhibits formation of glycan chains
            Inhibits formation of peptidoglycans and cell wall
             construction
            Does not cross lipid membrane of Gram -
                Gram - organisms innately resistant
       Important in treating infections caused by penicillin
        resistant Gram + organisms
       Must be given intravenously due to poor absorption from
        intestinal tract
       Acquired resistance most often due to alterations in side
        chain of NAM molecule
            Prevents binding of vancomycin to NAM component of glycan
MECHANISMS OF ACTION
OF ANTIBACTERIAL DRUGS
   Bacitracin
       Interferes with transport of peptidoglycan
        precursors across cytoplasmic membrane
       Toxicity limits use to topical applications
       Common ingredient in non-prescription first-
        aid ointments
MECHANISMS OF ACTION
OF ANTIBACTERIAL DRUGS
   Inhibition of protein synthesis
       Structure of prokaryotic ribosome acts as target for
        many antimicrobials of this class
            Differences in prokaryotic and eukaryotic ribosomes
             responsible for selective toxicity
       Drugs of this class include
            Aminoglycosides
            Tetracyclins
            Macrolids
            Chloramphenicol
MECHANISMS OF ACTION
OF ANTIBACTERIAL DRUGS
   Aminoglycosides
       Irreversibly binds to 30S
        ribosomal subunit
            Causes distortion and
             malfunction of ribosome
            Blocks initiation
             translation
                Causes misreading of
                 mRNA
       Not effective against
        anaerobes, enterococci
        and streptococci
       Often used in synergistic
        combination with β-lactam
        drugs
            Allows aminoglycosides to
             enter cells that are often
             resistant
MECHANISMS OF ACTION OF
ANTIBACTERIAL DRUGS
    Examples of
     aminoglycosides include
         Gentamicin,
          streptomycin and
          tobramycin
    Side effects with
     extended use include
         Otto toxicity
         Nephrotoxicity
MECHANISMS OF ACTION
OF ANTIBACTERIAL DRUGS
   Tetracyclins
       Reversibly bind 30S
        ribosomal subunit
            Blocks attachment of
             tRNA to ribosome
                Prevents continuation of
                 protein synthesis
       Effective against certain
        Gram + and Gram -
       Newer tetracyclines such
        as doxycycline have longer
        half-life
            Allows for less frequent
             dosing
MECHANISMS OF ACTION OF
ANTIBACTERIAL DRUGS

    Resistance due to
     decreased accumulation
     by bacterial cells
    Can cause discoloration
     of teeth if taken as
     young child
MECHANISMS OF ACTION OF
ANTIBACTERIAL DRUGS
   Macrolids
       Reversibly binds to 50S
        ribosome
            Prevents continuation of
             protein synthesis
       Effective against variety of
        Gram + organisms and
        those responsible for
        atypical pneumonia
       Often drug of choice for
        patients allergic to
        penicillin
       Macrolids include
            Erythromycin,
             clarithromycin and
             azithromycin
MECHANISMS OF ACTION OF
ANTIBACTERIAL DRUGS
    Resistance can occur
     via modification of RNA
     target
         Other mechanisms of
          resistance include
          production of enzyme
          that chemically
          modifies drug as well
          as alterations that
          result in decreased
          uptake of drug
MECHANISMS OF ACTION
OF ANTIBACTERIAL DRUGS
   Chloramphenicol
       Binds to 50S ribosomal
        subunit
            Prevents peptide bonds
             from forming and
             blocking proteins
             synthesis
       Effective against a wide
        variety of organisms
       Generally used as drug
        of last resort for life-
        threatening infections
       Rare but lethal side
        effect is aplastic anemia
MECHANISMS OF ACTION
OF ANTIBACTERIAL DRUGS
   Inhibition of nucleic acid synthesis
       These include
          Fluoroquinolones
          Rifamycins
MECHANISMS OF ACTION
OF ANTIBACTERIAL DRUGS
   Fluoroquinolones
       Inhibit action of topoisomerase DNA gyrase
            Topoisomerase maintains supercoiling of DNA
       Effective against Gram + and Gram -
       Examples include
            Ciprofloxacin and ofloxacin
       Resistance due to alteration of DNA gyrase
MECHANISMS OF ACTION
OF ANTIBACTERIAL DRUGS
   Rifamycins
       Block prokaryotic RNA polymerase
            Block initiation of transcription
       Rifampin most widely used rifamycins
       Effective against many Gram + and some Gram - as
        well as members of genus Mycobacterium
       Primarily used to treat tuberculosis and Hansen’s
        disease as well as preventing meningitis after exposure
        to N. meningitidis
       Resistance due to mutation coding RNA polymerase
            Resistance develops rapidly
MECHANISMS OF ACTION
OF ANTIBACTERIAL DRUGS
   Inhibition of metabolic
    pathways
       Relatively few
       Most useful are folate
        inhibitors
            Mode of actions to
             inhibit the production
             of folic acid
       Antimicrobials in this
        class include
            Sulfonamides
            Trimethoprim
MECHANISMS OF ACTION
OF ANTIBACTERIAL DRUGS
   Sulfonamides
       Group of related compounds
            Collectively called sulfa drugs
       Inhibit growth of Gram + and Gram - organisms
            Through competitive inhibition of enzyme that aids in
             production of folic acid
       Structurally similar to para-aminobenzoic acid
            Substrate in folic acid pathway
       Human cells lack specific enzyme in folic acid pathway
            Basis for selective toxicity
       Resistance due to plasmid
            Plasmid codes for enzyme that has lower affinity to drug
MECHANISMS OF ACTION
OF ANTIBACTERIAL DRUGS
   Trimethoprim
       Inhibits folic acid production
            Interferes with activity of enzyme following enzyme
             inhibited by sulfonamides
       Often used synergistically with sulfonamide
       Most common mechanism of resistance is
        plasmid encoded alternative enzyme
            Genes encoding resistant to sulfonamide and
             trimethoprim are often carried on same plasmid
MECHANISMS OF ACTION
OF ANTIBACTERIAL DRUGS
   Interference with cell
    membrane integrity
       Few damage cell
        membrane
            Polymixn B most common
                Common ingredient in
                 first-aid skin ointments
       Binds membrane of Gram
        - cells
            Alters permeability
                Leads to leakage of cell
                 and cell death
            Also bind eukaryotic cells
             but to lesser extent
                Limits use to topical
                 application
RESISTANCE TO
ANTIMICROBIAL DRUGS
   Mechanisms of resistance
       Drug inactivating enzymes
            Some organisms produce
             enzymes that chemically modify
             drug
                Penicillinase breaks β-lactam ring
                 of penicillin antibiotics
       Alteration of target molecule
            Minor structural changes in
             antibiotic target can prevent
             binding
                Changes in ribosomal RNA prevent
                 macrolids from binding to
                 ribosomal subunits
SUSCEPTIBILITY OF BACTERIAL
TO ANTIMICROBIAL DRUG
               Mechanisms of resistance
                   Decreased uptake of the drug
                        Alterations in porin proteins
                         decrease permeability of cells
                            Prevents certain drugs from
                             entering
                   Increased elimination of the drug
                        Some organisms produce efflux
                         pumps
                            Increases overall capacity of
                             organism to eliminate drug
                                Enables organism to resist
                                  higher concentrations of
                                  drug
                                Tetracycline resistance
ANTIMICROBIAL
SUSCEPTIBILITY TESTING
   Probably the most
    widely used testing
    method is the disk-
    diffusion method, also
    known as the Kirby-
    Bauer test.
SUSCEPTIBILITY OF BACTERIAL
TO ANTIMICROBIAL DRUG

   Conventional disc diffusion
    method
       Kirby-Bauer disc diffusion
        routinely used to
        qualitatively determine
        susceptibility
       Standard concentration of       Clear zone of inhibition
        strain uniformly spread of
                                         around disc reflects
        standard media
                                         susceptibility
       Discs impregnated with
        specific concentration of
                                             Based on size of zone
        antibiotic placed on plate            organism can be
        and incubated                         described as susceptible
                                              or resistant
EFFECTS OF
COMBINATIONS OF DRUGS
Sometimes the chemotherapeutic effects of
 two drugs given simultaneously is greater than
 the effect of either given alone.
 This is called synergism. For example,
 penicillin and streptomycin in the treatment
 of bacterial endocarditis. Damage to
 bacterial cell walls by penicillin makes it
 easier for streptomycin to enter.
EFFECTS OF
COMBINATIONS OF DRUGS
 Other combinations of drugs can be
  antagonistic.
 For example, the simultaneous use of penicillin
  and tetracycline is often less effective than
  when wither drugs is used alone. By stopping
  the growth of the bacteria, the
  bacteriostatic drug tetracycline interferes
  with the action of penicillin, which requires
  bacterial growth.
EFFECTS OF
COMBINATIONS OF DRUGS
    Combinations of antimicrobial drugs should
     be used only for:
    1.   To prevent or minimize the emergence of
         resistant strains.
    2.   To take advantage of the synergistic effect.
    3.   To lessen the toxicity of individual drugs.

Contenu connexe

Tendances

2. Choice and combined use of Anti-microbial agents
2. Choice and combined use of Anti-microbial agents2. Choice and combined use of Anti-microbial agents
2. Choice and combined use of Anti-microbial agentsJagirPatel3
 
Pharmacology of Cephalosporins
Pharmacology of CephalosporinsPharmacology of Cephalosporins
Pharmacology of CephalosporinsANUSHA SHAJI
 
Antimicrobial agents Protein Synthesis Inhibitors and DNA gyrase inhibitors
Antimicrobial agents Protein Synthesis Inhibitors and DNA gyrase inhibitorsAntimicrobial agents Protein Synthesis Inhibitors and DNA gyrase inhibitors
Antimicrobial agents Protein Synthesis Inhibitors and DNA gyrase inhibitorsPravin Prasad
 
Aminoglycoside ppt
Aminoglycoside pptAminoglycoside ppt
Aminoglycoside pptneetu ojha
 
Introduction to antimicrobials
Introduction to antimicrobialsIntroduction to antimicrobials
Introduction to antimicrobialsZainab&Sons
 
Basics of Antimicrobial Drugs
Basics of Antimicrobial DrugsBasics of Antimicrobial Drugs
Basics of Antimicrobial DrugsASSOCHAM
 
3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)
3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)
3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)Saminathan Kayarohanam
 

Tendances (20)

2. Choice and combined use of Anti-microbial agents
2. Choice and combined use of Anti-microbial agents2. Choice and combined use of Anti-microbial agents
2. Choice and combined use of Anti-microbial agents
 
Aminoglycoside antibiotics
Aminoglycoside antibioticsAminoglycoside antibiotics
Aminoglycoside antibiotics
 
Antibiotics
Antibiotics Antibiotics
Antibiotics
 
Pharmacology of Cephalosporins
Pharmacology of CephalosporinsPharmacology of Cephalosporins
Pharmacology of Cephalosporins
 
Macrolides Pharmacology
Macrolides PharmacologyMacrolides Pharmacology
Macrolides Pharmacology
 
Penicillins
PenicillinsPenicillins
Penicillins
 
Aminoglycosides Antibiotic's
Aminoglycosides Antibiotic'sAminoglycosides Antibiotic's
Aminoglycosides Antibiotic's
 
Pharmacology of Antibacterial agents
Pharmacology of Antibacterial agentsPharmacology of Antibacterial agents
Pharmacology of Antibacterial agents
 
Antimicrobial agents Protein Synthesis Inhibitors and DNA gyrase inhibitors
Antimicrobial agents Protein Synthesis Inhibitors and DNA gyrase inhibitorsAntimicrobial agents Protein Synthesis Inhibitors and DNA gyrase inhibitors
Antimicrobial agents Protein Synthesis Inhibitors and DNA gyrase inhibitors
 
Aminoglycosides Antibiotic
Aminoglycosides AntibioticAminoglycosides Antibiotic
Aminoglycosides Antibiotic
 
Aminoglycoside ppt
Aminoglycoside pptAminoglycoside ppt
Aminoglycoside ppt
 
Introduction to antimicrobials
Introduction to antimicrobialsIntroduction to antimicrobials
Introduction to antimicrobials
 
Basics of Antimicrobial Drugs
Basics of Antimicrobial DrugsBasics of Antimicrobial Drugs
Basics of Antimicrobial Drugs
 
Penicillins (VK)
Penicillins (VK)Penicillins (VK)
Penicillins (VK)
 
Antimicrobial agents
Antimicrobial agentsAntimicrobial agents
Antimicrobial agents
 
Streptomycin
StreptomycinStreptomycin
Streptomycin
 
Cephalosporin Antibiotics
Cephalosporin AntibioticsCephalosporin Antibiotics
Cephalosporin Antibiotics
 
3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)
3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)
3. ANTIBIOTIC (PROTEIN SYNTHESIS INHIBITORS)
 
Azithromycin
AzithromycinAzithromycin
Azithromycin
 
Aminoglycosides
AminoglycosidesAminoglycosides
Aminoglycosides
 

En vedette

Antiviral drugs
Antiviral drugsAntiviral drugs
Antiviral drugsCCRMHZN
 
Introduction to sulphonamides, trimethoprim, quinolones, penicillins, cephalo...
Introduction to sulphonamides, trimethoprim, quinolones, penicillins, cephalo...Introduction to sulphonamides, trimethoprim, quinolones, penicillins, cephalo...
Introduction to sulphonamides, trimethoprim, quinolones, penicillins, cephalo...Subramani Parasuraman
 
Aminoglycosides(medicinal chemistry by p.ravisankar)
Aminoglycosides(medicinal chemistry by p.ravisankar)Aminoglycosides(medicinal chemistry by p.ravisankar)
Aminoglycosides(medicinal chemistry by p.ravisankar)Dr. Ravi Sankar
 
ما هي كلوستريديم ديفيسيل ؟
ما هي كلوستريديم  ديفيسيل ؟ما هي كلوستريديم  ديفيسيل ؟
ما هي كلوستريديم ديفيسيل ؟Univ. of Tripoli
 
Antimicrobial
AntimicrobialAntimicrobial
Antimicrobialgirlie
 
Tpibaru8
Tpibaru8Tpibaru8
Tpibaru8andreei
 
Sulfonamides and trimethoprim
Sulfonamides and trimethoprimSulfonamides and trimethoprim
Sulfonamides and trimethoprimAbhinav Sawhney
 
Folic Acid Synthesis Inhibitors
Folic Acid Synthesis InhibitorsFolic Acid Synthesis Inhibitors
Folic Acid Synthesis InhibitorsDr Shah Murad
 
Antimicrobial 3 protein synthesis inhibitors
Antimicrobial 3 protein synthesis inhibitorsAntimicrobial 3 protein synthesis inhibitors
Antimicrobial 3 protein synthesis inhibitorsAseenat Mansour
 
DIARIO DE CIENCIAS PSÍQUICAS Nº1 - marzo 2017
DIARIO DE CIENCIAS PSÍQUICAS  Nº1 - marzo 2017DIARIO DE CIENCIAS PSÍQUICAS  Nº1 - marzo 2017
DIARIO DE CIENCIAS PSÍQUICAS Nº1 - marzo 2017cienciaspsiquicas
 
Protein synthesis inhibitor antibiotics
Protein synthesis inhibitor antibioticsProtein synthesis inhibitor antibiotics
Protein synthesis inhibitor antibioticsRukiga District
 
Ch 20_lecture_presentation
 Ch 20_lecture_presentation Ch 20_lecture_presentation
Ch 20_lecture_presentationkevperrino
 
Tuberculosis and anti tubercular drugs
Tuberculosis and anti tubercular drugsTuberculosis and anti tubercular drugs
Tuberculosis and anti tubercular drugsNarasimha Kumar G V
 

En vedette (20)

Introduction to antifungal drugs
Introduction to antifungal drugsIntroduction to antifungal drugs
Introduction to antifungal drugs
 
Antiviral drugs
Antiviral drugsAntiviral drugs
Antiviral drugs
 
Antifungal drugs
Antifungal drugsAntifungal drugs
Antifungal drugs
 
Antifungal drugs-Antibiotics
Antifungal drugs-AntibioticsAntifungal drugs-Antibiotics
Antifungal drugs-Antibiotics
 
Introduction to sulphonamides, trimethoprim, quinolones, penicillins, cephalo...
Introduction to sulphonamides, trimethoprim, quinolones, penicillins, cephalo...Introduction to sulphonamides, trimethoprim, quinolones, penicillins, cephalo...
Introduction to sulphonamides, trimethoprim, quinolones, penicillins, cephalo...
 
Aminoglycosides(medicinal chemistry by p.ravisankar)
Aminoglycosides(medicinal chemistry by p.ravisankar)Aminoglycosides(medicinal chemistry by p.ravisankar)
Aminoglycosides(medicinal chemistry by p.ravisankar)
 
ما هي كلوستريديم ديفيسيل ؟
ما هي كلوستريديم  ديفيسيل ؟ما هي كلوستريديم  ديفيسيل ؟
ما هي كلوستريديم ديفيسيل ؟
 
Antimicrobial
AntimicrobialAntimicrobial
Antimicrobial
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Tpibaru8
Tpibaru8Tpibaru8
Tpibaru8
 
Sulfonamides and trimethoprim
Sulfonamides and trimethoprimSulfonamides and trimethoprim
Sulfonamides and trimethoprim
 
Folic Acid Synthesis Inhibitors
Folic Acid Synthesis InhibitorsFolic Acid Synthesis Inhibitors
Folic Acid Synthesis Inhibitors
 
Antimicrobial 3 protein synthesis inhibitors
Antimicrobial 3 protein synthesis inhibitorsAntimicrobial 3 protein synthesis inhibitors
Antimicrobial 3 protein synthesis inhibitors
 
DIARIO DE CIENCIAS PSÍQUICAS Nº1 - marzo 2017
DIARIO DE CIENCIAS PSÍQUICAS  Nº1 - marzo 2017DIARIO DE CIENCIAS PSÍQUICAS  Nº1 - marzo 2017
DIARIO DE CIENCIAS PSÍQUICAS Nº1 - marzo 2017
 
Protein synthesis inhibitor antibiotics
Protein synthesis inhibitor antibioticsProtein synthesis inhibitor antibiotics
Protein synthesis inhibitor antibiotics
 
Ch 20_lecture_presentation
 Ch 20_lecture_presentation Ch 20_lecture_presentation
Ch 20_lecture_presentation
 
sulfoamide
sulfoamidesulfoamide
sulfoamide
 
Tuberculosis and anti tubercular drugs
Tuberculosis and anti tubercular drugsTuberculosis and anti tubercular drugs
Tuberculosis and anti tubercular drugs
 
Antimicrobials
AntimicrobialsAntimicrobials
Antimicrobials
 
2.sulfonamides
2.sulfonamides2.sulfonamides
2.sulfonamides
 

Similaire à Antimicrobial drugs corrected1 300409

ANTIBIOTICS CHEMICAL HAZARDS BY ASHOK SIR
ANTIBIOTICS CHEMICAL HAZARDS BY ASHOK SIRANTIBIOTICS CHEMICAL HAZARDS BY ASHOK SIR
ANTIBIOTICS CHEMICAL HAZARDS BY ASHOK SIRDEVIKA ANTHARJANAM
 
chemotherapy-181027041852-1.pdf
chemotherapy-181027041852-1.pdfchemotherapy-181027041852-1.pdf
chemotherapy-181027041852-1.pdfmousaderhem1
 
MECHANISMS OF ANTIBACTERIAL ACTION.
MECHANISMS OF ANTIBACTERIAL ACTION.MECHANISMS OF ANTIBACTERIAL ACTION.
MECHANISMS OF ANTIBACTERIAL ACTION.Dr. Ravi Sankar
 
Antimicrobial Agents and Antimicrobial Resistance.pptx
Antimicrobial Agents and Antimicrobial Resistance.pptxAntimicrobial Agents and Antimicrobial Resistance.pptx
Antimicrobial Agents and Antimicrobial Resistance.pptxDr. Rakesh Prasad Sah
 
1 Antibiotics resistance mechanism and Antibiotics Stewardship program.pptx
1 Antibiotics resistance mechanism and Antibiotics Stewardship program.pptx1 Antibiotics resistance mechanism and Antibiotics Stewardship program.pptx
1 Antibiotics resistance mechanism and Antibiotics Stewardship program.pptxchristomlin11
 
Antimicrobial 3 wafaa
Antimicrobial 3 wafaaAntimicrobial 3 wafaa
Antimicrobial 3 wafaawafaa ahmed
 
Antibacterial therapy by Dr. Rakesh Prasad Sah
Antibacterial therapy by Dr. Rakesh Prasad SahAntibacterial therapy by Dr. Rakesh Prasad Sah
Antibacterial therapy by Dr. Rakesh Prasad SahDr. Rakesh Prasad Sah
 
Antibiotic sensitivity and resistance .pptx seminar 2
Antibiotic sensitivity and resistance .pptx seminar 2Antibiotic sensitivity and resistance .pptx seminar 2
Antibiotic sensitivity and resistance .pptx seminar 2Dr. Mitali Thamke
 
Lecture 6 protein synthesis inhibiting antibiotics
Lecture 6 protein synthesis inhibiting antibioticsLecture 6 protein synthesis inhibiting antibiotics
Lecture 6 protein synthesis inhibiting antibioticsana munir
 
Antibacterial therapy by Dr. Rakesh Prasad Sah
Antibacterial therapy by Dr. Rakesh Prasad SahAntibacterial therapy by Dr. Rakesh Prasad Sah
Antibacterial therapy by Dr. Rakesh Prasad SahDr. Rakesh Prasad Sah
 
Antibiotics-IntroductiontoClassification.ppt
Antibiotics-IntroductiontoClassification.pptAntibiotics-IntroductiontoClassification.ppt
Antibiotics-IntroductiontoClassification.pptRashmiShah46
 
Antibiotics: Introduction to classification
Antibiotics: Introduction to classificationAntibiotics: Introduction to classification
Antibiotics: Introduction to classificationBhoj Raj Singh
 
Antimicrobial agents.AMCC-3.ppt
Antimicrobial agents.AMCC-3.pptAntimicrobial agents.AMCC-3.ppt
Antimicrobial agents.AMCC-3.pptMushfiqulIslam9
 

Similaire à Antimicrobial drugs corrected1 300409 (20)

ANTIBIOTICS CHEMICAL HAZARDS BY ASHOK SIR
ANTIBIOTICS CHEMICAL HAZARDS BY ASHOK SIRANTIBIOTICS CHEMICAL HAZARDS BY ASHOK SIR
ANTIBIOTICS CHEMICAL HAZARDS BY ASHOK SIR
 
chemotherapy-181027041852-1.pdf
chemotherapy-181027041852-1.pdfchemotherapy-181027041852-1.pdf
chemotherapy-181027041852-1.pdf
 
Chemotherapy
ChemotherapyChemotherapy
Chemotherapy
 
MECHANISMS OF ANTIBACTERIAL ACTION.
MECHANISMS OF ANTIBACTERIAL ACTION.MECHANISMS OF ANTIBACTERIAL ACTION.
MECHANISMS OF ANTIBACTERIAL ACTION.
 
Antimicrobial Agents and Antimicrobial Resistance.pptx
Antimicrobial Agents and Antimicrobial Resistance.pptxAntimicrobial Agents and Antimicrobial Resistance.pptx
Antimicrobial Agents and Antimicrobial Resistance.pptx
 
Chemotherapy (2)
Chemotherapy (2)Chemotherapy (2)
Chemotherapy (2)
 
1 Antibiotics resistance mechanism and Antibiotics Stewardship program.pptx
1 Antibiotics resistance mechanism and Antibiotics Stewardship program.pptx1 Antibiotics resistance mechanism and Antibiotics Stewardship program.pptx
1 Antibiotics resistance mechanism and Antibiotics Stewardship program.pptx
 
Antimicrobial 3 wafaa
Antimicrobial 3 wafaaAntimicrobial 3 wafaa
Antimicrobial 3 wafaa
 
Antibacterial therapy by Dr. Rakesh Prasad Sah
Antibacterial therapy by Dr. Rakesh Prasad SahAntibacterial therapy by Dr. Rakesh Prasad Sah
Antibacterial therapy by Dr. Rakesh Prasad Sah
 
Antibiotic sensitivity and resistance .pptx seminar 2
Antibiotic sensitivity and resistance .pptx seminar 2Antibiotic sensitivity and resistance .pptx seminar 2
Antibiotic sensitivity and resistance .pptx seminar 2
 
Lecture 6 protein synthesis inhibiting antibiotics
Lecture 6 protein synthesis inhibiting antibioticsLecture 6 protein synthesis inhibiting antibiotics
Lecture 6 protein synthesis inhibiting antibiotics
 
Antibacterial therapy by Dr. Rakesh Prasad Sah
Antibacterial therapy by Dr. Rakesh Prasad SahAntibacterial therapy by Dr. Rakesh Prasad Sah
Antibacterial therapy by Dr. Rakesh Prasad Sah
 
vsv6
vsv6vsv6
vsv6
 
Antibiotics introduction to classification
Antibiotics introduction to classificationAntibiotics introduction to classification
Antibiotics introduction to classification
 
Antibiotics-IntroductiontoClassification.ppt
Antibiotics-IntroductiontoClassification.pptAntibiotics-IntroductiontoClassification.ppt
Antibiotics-IntroductiontoClassification.ppt
 
Antibiotics: Introduction to classification
Antibiotics: Introduction to classificationAntibiotics: Introduction to classification
Antibiotics: Introduction to classification
 
Shreya modi
Shreya modiShreya modi
Shreya modi
 
Antimicrobial agents.AMCC-3.ppt
Antimicrobial agents.AMCC-3.pptAntimicrobial agents.AMCC-3.ppt
Antimicrobial agents.AMCC-3.ppt
 
Chapter 10 A.pdf
Chapter 10 A.pdfChapter 10 A.pdf
Chapter 10 A.pdf
 
Chapter 10.pdf
Chapter 10.pdfChapter 10.pdf
Chapter 10.pdf
 

Antimicrobial drugs corrected1 300409

  • 2. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Mechanism of action include:  Inhibition of cell wall synthesis  Inhibition of protein synthesis  Inhibition of nucleic acid synthesis  Inhibition of metabolic pathways  Interference with cell membrane integrity
  • 3. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Inhibition of Cell wall synthesis  Bacteria cell wall unique in construction  Contains peptidoglycan  Antimicrobials that interfere with the synthesis of cell wall do not interfere with eukaryotic cell  Due to the lack of cell wall in animal cells and differences in cell wall in plant cells  These drugs have very high therapeutic index  Low toxicity with high effectiveness  Antimicrobials of this class include  β lactam drugs  Vancomycin  Bacitracin
  • 4. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Penicillins and cephalosporins  Part of group of drugs called β –lactams  Have shared chemical structure called β-lactam ring  Competitively inhibits function of penicillin- binding proteins  Inhibits peptide bridge formation between glycan molecules  This causes the cell wall to develop weak points at the growth sites and become fragile.
  • 5. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  The weakness in the cell wall causes the cell to lyze.
  • 6. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  The weakness in the cell wall causes the cell to lyze.  Penicillins and cephalosporins are considered bactericidal.  Penicillins are more effective against Gram+ bacteria. This is because Gram + bacteria have penicillin binding proteins on their walls.
  • 7. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  The cephalosporins  Chemical structures make them resistant to inactivation by certain β-lactamases  Tend to have low affinity to penicillin-binding proteins of Gram + bacteria, therefore, are most effective against Gram – bacteria.  Chemically modified to produce family of related compounds  First, second, third and fourth generation cephalosporins
  • 8. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Vancomycin  Inhibits formation of glycan chains  Inhibits formation of peptidoglycans and cell wall construction  Does not cross lipid membrane of Gram -  Gram - organisms innately resistant  Important in treating infections caused by penicillin resistant Gram + organisms  Must be given intravenously due to poor absorption from intestinal tract  Acquired resistance most often due to alterations in side chain of NAM molecule  Prevents binding of vancomycin to NAM component of glycan
  • 9. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Bacitracin  Interferes with transport of peptidoglycan precursors across cytoplasmic membrane  Toxicity limits use to topical applications  Common ingredient in non-prescription first- aid ointments
  • 10. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Inhibition of protein synthesis  Structure of prokaryotic ribosome acts as target for many antimicrobials of this class  Differences in prokaryotic and eukaryotic ribosomes responsible for selective toxicity  Drugs of this class include  Aminoglycosides  Tetracyclins  Macrolids  Chloramphenicol
  • 11. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Aminoglycosides  Irreversibly binds to 30S ribosomal subunit  Causes distortion and malfunction of ribosome  Blocks initiation translation  Causes misreading of mRNA  Not effective against anaerobes, enterococci and streptococci  Often used in synergistic combination with β-lactam drugs  Allows aminoglycosides to enter cells that are often resistant
  • 12. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Examples of aminoglycosides include  Gentamicin, streptomycin and tobramycin  Side effects with extended use include  Otto toxicity  Nephrotoxicity
  • 13. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Tetracyclins  Reversibly bind 30S ribosomal subunit  Blocks attachment of tRNA to ribosome  Prevents continuation of protein synthesis  Effective against certain Gram + and Gram -  Newer tetracyclines such as doxycycline have longer half-life  Allows for less frequent dosing
  • 14. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Resistance due to decreased accumulation by bacterial cells  Can cause discoloration of teeth if taken as young child
  • 15. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Macrolids  Reversibly binds to 50S ribosome  Prevents continuation of protein synthesis  Effective against variety of Gram + organisms and those responsible for atypical pneumonia  Often drug of choice for patients allergic to penicillin  Macrolids include  Erythromycin, clarithromycin and azithromycin
  • 16. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Resistance can occur via modification of RNA target  Other mechanisms of resistance include production of enzyme that chemically modifies drug as well as alterations that result in decreased uptake of drug
  • 17. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Chloramphenicol  Binds to 50S ribosomal subunit  Prevents peptide bonds from forming and blocking proteins synthesis  Effective against a wide variety of organisms  Generally used as drug of last resort for life- threatening infections  Rare but lethal side effect is aplastic anemia
  • 18. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Inhibition of nucleic acid synthesis  These include  Fluoroquinolones  Rifamycins
  • 19. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Fluoroquinolones  Inhibit action of topoisomerase DNA gyrase  Topoisomerase maintains supercoiling of DNA  Effective against Gram + and Gram -  Examples include  Ciprofloxacin and ofloxacin  Resistance due to alteration of DNA gyrase
  • 20. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Rifamycins  Block prokaryotic RNA polymerase  Block initiation of transcription  Rifampin most widely used rifamycins  Effective against many Gram + and some Gram - as well as members of genus Mycobacterium  Primarily used to treat tuberculosis and Hansen’s disease as well as preventing meningitis after exposure to N. meningitidis  Resistance due to mutation coding RNA polymerase  Resistance develops rapidly
  • 21. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Inhibition of metabolic pathways  Relatively few  Most useful are folate inhibitors  Mode of actions to inhibit the production of folic acid  Antimicrobials in this class include  Sulfonamides  Trimethoprim
  • 22. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Sulfonamides  Group of related compounds  Collectively called sulfa drugs  Inhibit growth of Gram + and Gram - organisms  Through competitive inhibition of enzyme that aids in production of folic acid  Structurally similar to para-aminobenzoic acid  Substrate in folic acid pathway  Human cells lack specific enzyme in folic acid pathway  Basis for selective toxicity  Resistance due to plasmid  Plasmid codes for enzyme that has lower affinity to drug
  • 23. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Trimethoprim  Inhibits folic acid production  Interferes with activity of enzyme following enzyme inhibited by sulfonamides  Often used synergistically with sulfonamide  Most common mechanism of resistance is plasmid encoded alternative enzyme  Genes encoding resistant to sulfonamide and trimethoprim are often carried on same plasmid
  • 24. MECHANISMS OF ACTION OF ANTIBACTERIAL DRUGS  Interference with cell membrane integrity  Few damage cell membrane  Polymixn B most common  Common ingredient in first-aid skin ointments  Binds membrane of Gram - cells  Alters permeability  Leads to leakage of cell and cell death  Also bind eukaryotic cells but to lesser extent  Limits use to topical application
  • 25. RESISTANCE TO ANTIMICROBIAL DRUGS  Mechanisms of resistance  Drug inactivating enzymes  Some organisms produce enzymes that chemically modify drug  Penicillinase breaks β-lactam ring of penicillin antibiotics  Alteration of target molecule  Minor structural changes in antibiotic target can prevent binding  Changes in ribosomal RNA prevent macrolids from binding to ribosomal subunits
  • 26. SUSCEPTIBILITY OF BACTERIAL TO ANTIMICROBIAL DRUG  Mechanisms of resistance  Decreased uptake of the drug  Alterations in porin proteins decrease permeability of cells  Prevents certain drugs from entering  Increased elimination of the drug  Some organisms produce efflux pumps  Increases overall capacity of organism to eliminate drug  Enables organism to resist higher concentrations of drug  Tetracycline resistance
  • 27. ANTIMICROBIAL SUSCEPTIBILITY TESTING  Probably the most widely used testing method is the disk- diffusion method, also known as the Kirby- Bauer test.
  • 28. SUSCEPTIBILITY OF BACTERIAL TO ANTIMICROBIAL DRUG  Conventional disc diffusion method  Kirby-Bauer disc diffusion routinely used to qualitatively determine susceptibility  Standard concentration of  Clear zone of inhibition strain uniformly spread of around disc reflects standard media susceptibility  Discs impregnated with specific concentration of  Based on size of zone antibiotic placed on plate organism can be and incubated described as susceptible or resistant
  • 29. EFFECTS OF COMBINATIONS OF DRUGS Sometimes the chemotherapeutic effects of two drugs given simultaneously is greater than the effect of either given alone.  This is called synergism. For example, penicillin and streptomycin in the treatment of bacterial endocarditis. Damage to bacterial cell walls by penicillin makes it easier for streptomycin to enter.
  • 30. EFFECTS OF COMBINATIONS OF DRUGS  Other combinations of drugs can be antagonistic.  For example, the simultaneous use of penicillin and tetracycline is often less effective than when wither drugs is used alone. By stopping the growth of the bacteria, the bacteriostatic drug tetracycline interferes with the action of penicillin, which requires bacterial growth.
  • 31. EFFECTS OF COMBINATIONS OF DRUGS  Combinations of antimicrobial drugs should be used only for: 1. To prevent or minimize the emergence of resistant strains. 2. To take advantage of the synergistic effect. 3. To lessen the toxicity of individual drugs.